Dagrocorat

From WikiMD's WELLNESSPEDIA

Dagrocorat is a nonsteroidal but steroid-like selective glucocorticoid receptor modulator (SGRM) which was under development for the treatment of rheumatoid arthritis but was never marketed.

Dagrocorat
Dagrocorat

Developmental code name[edit]

The delopmental code names were: PF-00251802, PF-251802

Never marketed[edit]

The medication was never marketed by the pharmaceutical company for unknown reasons.

Mechanism of action[edit]

Dagrocorat is a novel and dissociated glucocorticoid receptor agonist.

Originator[edit]

Pfizer

Class of drug[edit]

Anti-inflammatories; Antirheumatics; Phenanthrenes; Pyridines; Small molecules

Orphan Drug Status[edit]

No

New Molecular Entity[edit]

Yes

Highest Development Phases[edit]

Phase 1

Current status[edit]

Discontinued

Proposed indication[edit]

Rheumatoid arthritis

Most Recent Events[edit]

  • 27 Jan 2010Discontinued - Phase-I for Rheumatoid arthritis in USA (unspecified route)
  • 03 Oct 2008Phase-I trials in Rheumatoid arthritis in USA (unspecified route)

Related molecules[edit]

Dagrocorat-2